Articles From: MEI Pharma Reports Significant Clinical Activity In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia to PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes


Company Outlines Plans for Phase III Registration Study San Diego , Dec.
Sign-up for MEI Pharma Reports Significant Clinical Activity In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia investment picks
American Express (NYSE:AXP), the Brooklyn Nets and Barclays Center are launching a pilot program of the Brooklyn eWallet, a digital payment solution integrated directly into the Brooklyn Nets mobile application 1 .
Sign-up for American Express, Brooklyn Nets, and Barclays Center Give Guests the Ability to Pay with Smartphones at Events investment picks
2014/11/4
New Business Line to be Headed by Industry Veteran Marvin Gidney IRVINE, Calif.
Sign-up for Pro-Dex, Inc. Announces Launch Of Engineering Services Division investment picks
CHICAGO , Dec.
Sign-up for Envestnet's 2015 Market Outlook Webinar asks, "Will the Bull Continue?" investment picks
Terex Corporation (NYSE:TEX) today announced income from continuing operations of $58.7 million, or $0.51 per share for the third quarter of 2014, and excluding certain items, income from continuing operations as adjusted was $67.8 million, or $0.59 per share.
Sign-up for Terex Announces Third Quarter 2014 Results investment picks
AudaExplore, the US business unit of Solera Holdings, Inc. (NYSE: SLH) and a leading data-driven solution provider to insurance carriers, repairers, dealerships, fleet owners and suppliers, and the Collision Repair Education Foundation, a philanthropic organization that enables education activities for the collision repair industry, announced that AudaExplore has been recognized as a lifetime donor of over $5 million in in-kind and cash donations.
Sign-up for Collision Repair Education Foundation Recognizes AudaExplore as Lifetime Contributor of Over $5 Million in Donations investment picks
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) (“Eagle” or the “Company”) today announced positive results from a recently-conducted clinical trial of its bendamustine hydrochloride (“HCl”) product, in which the dose was delivered in a 50mL admixture in ten minutes (the “rapidly infused product”) versus a 500mL admixture in the 60-minute infusion required for Treanda ® (bendamustine HCl). In this study, Eagle’s rapidly infused product was found to be bioequivalent to Treanda, which was the primary endpoint of the study.
Sign-up for Eagle Pharmaceuticals Reports Positive Outcomes from Clinical Trial of Bendamustine HCl Product Delivered via Low-Volume, Rapidly Infused Admixture investment picks
CLEVELAND , Dec.
Sign-up for KeyCorp Fourth Quarter 2014 Earnings Release Date And Conference Call investment picks
Global Partners LP (NYSE: GLP) today reported financial results for the third quarter ended September 30, 2014.
Sign-up for Global Partners Reports Strong Financial Results for the Third Quarter of 2014 investment picks
Integrated Device Technology, Inc. ( IDT ® ) (NASDAQ:IDTI) today introduced a new family of magnetic induction wireless power transmitters designed for the next generation of wireless charging products, delivering greater flexibility and ease of use while reducing overall development cost through a high level of integration.
Sign-up for IDT Introduces New Family of Highly Efficient Wireless Power Transmitters, Targeting the Expanding Ecosystem of Wireless Charging Applications investment picks
2014/10/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0975393001&sourceType=1 http://media3.marketwire.com/logos/20120131-yama200.jpg TORONTO, ONTARIO --
Sign-up for Yamana Gold Announces Third Quarter 2014 Results investment picks
Family Dollar Stores, Inc. (“Family Dollar”) (NYSE:FDO), a leading national discount retailer offering name brands and quality, private brand merchandise, announced today that Institutional Shareholder Services (“ISS”), a leading independent proxy voting and corporate governance advisory firm, recommends that Family Dollar stockholders vote “ FOR ” the merger with Dollar Tree, Inc. (NASDAQ: DLTR) at Family Dollar’s Special Meeting of Stockholders scheduled for January 22, 2015.
Sign-up for Leading Proxy Advisory Firm ISS Recommends Family Dollar Stockholders Vote “For” Merger with Dollar Tree investment picks
bluebird bio, Inc. (Nasdaq: BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that data from its ongoing Phase 1/2 HGB-205 and Northstar Studies of LentiGlobin BB305 Drug Product will be presented at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place December 6 – 9, 2014 in San Francisco, California.
Sign-up for bluebird bio to Present LentiGlobin Clinical Data at the American Society of Hematology Conference investment picks
CLEARWATER, Fla., Oct.
Sign-up for Tech Data Ranked Among Top 100 Cloud Service Providers by Talkin' Cloud investment picks
JINHUA, China, Oct.
Sign-up for Kandi's New Pure Electric Vehicle Model "Cyclone" Expected to Launch at Year End investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the third quarter ended September 30, 2014.
Sign-up for Antares Pharma Reports Third Quarter 2014 Operating and Financial Results investment picks
2014/11/20
DRA CRT Acquisition Corp.
Sign-up for DRA CRT Acquisition Corp. Declares Quarterly Dividend on Preferred Stock investment picks
Wells Fargo & Company (NYSE:WFC) announced today it hired Matt Wysong to lead the expansion of its Technology Banking Group in the Mountain States, with emphasis on Colorado, Utah, Arizona, Nevada, and Idaho.
Sign-up for Wells Fargo Adds Resources for Tech Sector in Mountain States investment picks
2014/12/10
Levi & Korsinsky is investigating the Board of Directors of Actuate Corporation (“Actuate” or “the Company”) (NasdaqGS: BIRT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to OpenText Corporation.
Sign-up for BIRT INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Actuate Corporation Regarding the Fairness of the Sale of the Company to OpenText Corporation -- BIRT investment picks
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Anne M.
Sign-up for Trevena Appoints Anne M. Phillips to the Board of Directors investment picks
2014/12/16
LONDON , December 16, 2014 /PRNewswire/ -- Royal Dutch Shell plc (NYSE: RDS.A) (NYSE: RDS.B) announces that on 16 December, 2014 it purchased for cancellation 650,000 "A" Shares at a price of 1974.26 pence per share.
Sign-up for Royal Dutch Shell plc - Buyback of Own Shares investment picks
INCLINE VILLAGE, Nev.
Sign-up for PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: MEI Pharma Reports Significant Clinical Activity In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia to PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent